''Microbubbles have been the earliest and most widely used ultrasound contrast agents by virtue of their unique features: such as non-toxicity, intravenous injectability, ability to cross the pulmonary capillary bed, and significant enhancement of echo ...'

''Initial reports from the 1960s describing the observations of ultrasound contrast enhancement by tiny gaseous bubbles during echocardiographic examinations prompted the development of the first ultrasound con- trast agent in the 1980s. Current ...'

''Ultrasonic molecular imaging employs contrast agents, such as microbubbles, nanoparticles, or liposomes, coated with ligands specific for receptors expressed on cells at sites of angiogenesis, inflammation, or thrombus. Concentration of these highly ...'

''This study aimed to determine whether the normal parotid gland (PG) and submandibular gland (SMG) can be used as reference standards for normal thyroid echogenicity. Methods In total, 1,302 consecutive patients with normal salivary glands were included ...'

''The 129-pound, mobile system features innovative quantitative features, stress echo and TEE capabilities, delivering exceptional value to healthcare providers looking for an affordable echo system. GE has enhanced the reach of the Vivid T8 by ...'

''The new technique aims to improve on conventional 3D echocardiography which is not yet routinely used, partly because of problems with the quality of images produced and difficulties in imaging the whole heart. A team of Oxford University biomedical ...'

''Echometrix, a Madison medical technology company, has received U.S. Food and Drug Administration approval to sell its EchoSoft ultrasound technology. We're very pleased to have reached this critical milestone, said chief executive Sam Adams. The ...'

''Dynarex Corporation, a leading manufacturer of a broad range of medical products located in Orangeburg, NY, is pleased to introduce Ultrasound Gel. The Ultrasound Gel is electroconductive gel media to facilitate the ultrasonic pulsed echo imaging system. ...'

''The U.S. Food and Drug Administration (FDA) cleared software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound ...'